Abalone Bio
PrivateLast Round
Grant
Apr 1, 2024
Total Funding Raised
$9.36M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Abalone Bio operates in Healthcare & Life Sciences and is based in Emeryville, California. Its latest recorded funding round was a Grant round in April 2024.
Abalone Bio is a biotechnology company that develops activating antibody-based therapeutics for challenging diseases, including cancer, pain, inflammatory conditions, and metabolic disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abalone Bio Comparables
Compare Abalone Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InterAx Biotech | 79% | |
| Octant | 79% | |
| Infinimmune | 78% |
For institutional investors. Book with your work email.
Abalone Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2024 | ||||
| Grant | Sep 12, 2022 | ||||
| Grant | Aug 1, 2022 | ||||
| Grant | Aug 19, 2021 | ||||
| Grant | Aug 19, 2021 | ||||
Grant | Feb 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Abalone Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| National Institute on Drug Abuse | Grant |
| Pioneer Fund | Accelerator |
| U.S. Department of Health and Human Services | Grant |
| NIH RADx | Grant |
| Friále | Accelerator |
| Breakthrough Energy Ventures | Accelerator |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 94% MoM.
- Mar 11, 2025
Partnering with the University of Pennsylvania to develop obesity drugs.
For institutional investors. Book with your work email.
Abalone Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Abalone Bio's valuation, stock price, and market status.
Is Abalone Bio a public or private company?
Abalone Bio is a private company.
What is the current stock price of Abalone Bio?
Abalone Bio is a private company, so its shares have no public market price. Caplight tracks Abalone Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Abalone Bio worth (valuation)?
Valuation information for Abalone Bio is not publicly available.
Can I buy Abalone Bio stock?
Abalone Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Abalone Bio's last funding round?
Abalone Bio's most recent funding round was Grant on April 1, 2024.
Who are the main investors in Abalone Bio?
Key investors in Abalone Bio include NIH RADx, Y Combinator, National Science Foundation.
Will Abalone Bio IPO soon?
No public IPO plans have been announced for Abalone Bio.
How can I track Abalone Bio secondary market activity?
Caplight tracks bids, offers, and trades in Abalone Bio's shares on secondary markets.